Earnings Feed
Start Free
Home/Filings/4/0001209191-17-038136
4//SEC Filing

NEOGENOMICS INC 4

Accession 0001209191-17-038136

$NEOCIK 0001077183operating
View on SEC.govCompany Profile

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 4:39 PM ET

Size

19.4 KB

Accession

0001209191-17-038136

Insider Transaction Report

Form 4
Period: 2017-06-02
NEOGENOMICS INCNEO
ROSS STEVEN A
CIO
Transactions
  • Exercise/Conversion

    Common Stock

    2017-06-02$3.93/sh+37,500$147,375→ 42,000 total
  • Exercise/Conversion

    Common Stock

    2017-06-02$4.78/sh+33,333$159,332→ 75,333 total
  • Sale

    Common Stock

    2017-06-02$7.79/sh−10,000$77,900→ 50,333 total
  • Sale

    Common stock

    2017-06-05$7.79/sh−45,833$357,039→ 4,500 total
  • Exercise of In-Money

    Stock Option (Right to buy)

    2017-06-02$3.93/sh−37,500$147,375→ 0 total
    Exercise: $3.93From: 2014-04-22Exp: 2018-04-22→ Common Stock (37,500 underlying)
  • Sale

    Common Stock

    2017-06-02$7.63/sh−15,000$114,450→ 60,333 total
  • Exercise of In-Money

    Stock Option (Right to Buy)

    2017-06-02$4.78/sh−33,333$159,332→ 33,667 total
    Exercise: $4.78From: 2016-05-06Exp: 2020-05-06→ Common Stock (67,000 underlying)
Holdings

  • Common Stock

    4,500

  • Stock Option (Right to Buy)

    Exercise: $7.15From: 2017-04-20Exp: 2021-04-20→ Common Stock (40,000 underlying)
    40,000

  • Stock Option (Right to Buy)

    Exercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (65,000 underlying)
    65,000
Footnotes (4)
  • [F1]On April 20, 2016, Mr. Ross was granted 40,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
  • [F2]On April 22, 2013, Mr. Ross was granted 150,000 stock options to purchase common stock of the Company. These options vest ratably on each of the next 4 anniversary dates of the grant date.
  • [F3]On May 6, 2015, Mr. Ross was granted 100,000 stock options to purchase common stock of the Company. These options vest ratably on each of the first three anniversary dates of the grant date. On May 9, 2016, Mr. Ross exercised 15,000 of these options leaving a balance of 85,000 options and on May 18, 2016, Mr. Ross exercised 18,000 of these options leaving a balance of 67,000 options. On June 2, 2017, Mr. Ross exercised 33,333 of these options leaving a balance of 33,667 options.
  • [F4]On April 28, 2017, Mr. Ross was granted 65,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

Documents

1 file

Issuer

NEOGENOMICS INC

CIK 0001077183

→
Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001077183

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:39 PM ET
Size
19.4 KB
View on SEC.gov